Topics

Oxis enters LOI to acquire Georgetown Translational; later closes M&A

15:40 EDT 11 Oct 2019 | Elsevier Business Intelligence

Oxis International Inc. executed a binding letter of intent to acquire privately held Georgetown Translational Pharmaceutical...

Original Article: Oxis enters LOI to acquire Georgetown Translational; later closes M&A

NEXT ARTICLE

More From BioPortfolio on "Oxis enters LOI to acquire Georgetown Translational; later closes M&A"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...